John P. Saharek - CEO & President, ImprimisRx at Harrow, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO & President, ImprimisRx
Stock Symbol
HROW, HROWL, HROWM on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by John P. Saharek since 4/21/2024

Holdings reported by John P. Saharek for Harrow, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 467K $10.8M $23.09 Apr 7, 2025 Direct
Performance Stock Unit 0 $0 $23.09 Apr 3, 2025 Direct Common Stock
Stock Option (Right to Buy) 0 Sep 11, 2024 Direct Common Stock

Transactions reported by John P. Saharek for Harrow, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.